The Lancet has published the results from the Valneva COVID-19 vaccine clinical trial. The paper, linked below, discusses how the Valneva vaccine (VLA2001) showed superior immunogenicity compared to the Oxford ChAdOx1 vaccine.

The vaccine is now licensed in the UK, EU, UAE, and Bahrain and endorsed by WHO as a result of this study.


The link to the paper is HERE